• Frontier investable areas in brain health with PsyMed Ventures

  • Feb 25 2025
  • Duración: 50 m
  • Podcast

Frontier investable areas in brain health with PsyMed Ventures

  • Resumen

  • Greg and Matias sit down with Brooks Leitner, the newest venture partner at PsyMed Ventures, to explore the future of brain and mental health investing. Brooks, an MD/PhD with deep experience from Yale and the NIH, shares his insights on how a human-first approach is reshaping neuroscience innovation and venture investing.

    In this episode, we discuss:

    • Broadening the Thesis: Evolving from a psychedelics-only focus to a comprehensive neuro investment strategy.
    • Human-First Research: Shifting from animal models to clinical insights for better brain therapies.
    • Key Investment Areas: Therapeutics, medical devices, diagnostics, consumer health, and AI-enabled care platforms.
    • Early-Stage Conviction: Leveraging a prepared mind to spot breakthrough opportunities.
    • Personal & Future Insights: Leadership challenges and the vision for the future of neuro investing.

    Credits:

    Created by Greg Kubin and Matias Serebrinsky
    Host: Matias Serebrinsky & Greg Kubin
    Produced by Jonathan A. Davis, Nico V. Rey & Caitlin Ner

    Find us at businesstrip.fm and psymed.ventures
    Follow us on Instagram and Twitter!
    Theme music by Dorian Love
    Additional Music: Distant Daze by Zack Frank

    Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre Frontier investable areas in brain health with PsyMed Ventures

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.